DJIA 16,908.13 -77.48 -0.46%
NASDAQ 4,394.78 -24.26 -0.55%
S&P 500 1,964.92 -7.91 -0.40%
market minute promo

2.95 0.02 (0.79%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PSTI $2.95 0.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.85
Previous Close $2.93
Daily Range $2.85 - $2.96
52-Week Range $2.85 - $4.63
Market Cap $200.6M
P/E Ratio -6.44
Dividend (Yield) $0.00 (0.0%)
Volume 110,822
Average Daily Volume 141,837
Current FY EPS -$0.48






Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders. Website:

News & Commentary

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

NIH's Human Placenta Project Is Validation For Placental Cells Curing Deadly Diseases

Pluristem Initiates Trial in South Korea - Analyst Blog

Pluristem Initiates Trial in South Korea - Analyst Blog

Israeli Biomed-Tech Companies Present Investment Opportunities

Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade

Sector Update: Healthcare

Pluristem's Preeclampsia Effort Pushes PLX Platform

Pipeline Progress at Pluristem - Analyst Blog

Pipeline Progress at Pluristem - Analyst Blog

Will Regeneron (REGN) Disappoint in Q4? - Analyst Blog

Company news for February 05, 2014 - Corporate Summary

See More PSTI News...

PSTI's Top Competitors

PSTI $2.95 (0.79%)
Current stock: PSTI
AMGN $118.82 (-0.63%)
Current stock: AMGN
GILD $89.08 (0.45%)
Current stock: GILD
BIIB $319.27 (-0.27%)
Current stock: BIIB